Influence of skeletal muscle and intermuscular fat on postoperative complications and long-term survival in rectal cancer patients
- PMID: 38293722
- PMCID: PMC10995272
- DOI: 10.1002/jcsm.13424
Influence of skeletal muscle and intermuscular fat on postoperative complications and long-term survival in rectal cancer patients
Abstract
Background: The body composition of patients with rectal cancer potentially affects postoperative outcomes. This study explored the correlations between skeletal muscle and adipose tissue quantified by computed tomography (CT) with postoperative complications and long-term prognosis in patients with rectal cancer after surgical resection.
Methods: This retrospective cohort study included patients with rectal cancer who underwent surgical resection at the Wuhan Union Hospital between 2014 and 2018. CT images within 3 months prior to the surgery were used to quantify the indices of skeletal muscle and adipose tissue at the levels of the third lumbar vertebra (L3) and umbilicus. Optimal cut-off values for each index were defined separately for males and females. Associations between body composition and postoperative complications, overall survival (OS), and disease-free survival (DFS) were evaluated using logistic and Cox proportional hazards models.
Results: We included 415 patients (240 males and 175 females; mean age: 57.8 ± 10.5 years). At the L3 level, a high skeletal muscle density (SMD; hazard ratio [HR]: 0.357, 95% confidence interval [CI]: 0.191-0.665, P = 0.001; HR: 0.571, 95% CI: 0.329-0.993, P = 0.047) and a high skeletal muscle index (SMI; HR: 0.435, 95% CI 0.254-0.747, P = 0.003; HR: 0.568, 95% CI: 0.359-0.897, P = 0.015) were independent prognostic factors for better OS and DFS. At the umbilical level, a large intermuscular fat area (IMFA; HR: 1.904, 95% CI: 1.068-3.395, P = 0.029; HR: 2.064, 95% CI: 1.299-3.280, P = 0.002) was an independent predictive factor for worse OS and DFS, and a high SMI (HR: 0.261, 95% CI: 0.132-0.517, P < 0.001; HR: 0.595, 95% CI: 0.387-0.913, P = 0.018) was an independent prognostic factor for better OS and DFS. The models combining body composition and clinical indicators had good predictive abilities for OS. The receiver operating characteristic areas under the curve were 0.848 and 0.860 at the L3 and umbilical levels, respectively (both P < 0.05).
Conclusions: No correlations existed between CT-quantified body composition parameters and postoperative complications. However, a high SMD and high SMI were significantly associated with longer OS and DFS at the L3 level, whereas a large IMFA and low SMI were associated with worse OS and DFS at the umbilical level. Combining CT-quantified body composition and clinical indicators could help physicians predict the prognosis of patients with rectal cancer after surgery.
Keywords: Disease‐free survival; Intermuscular fat; Overall survival; Postoperative complications; Rectal cancer; Skeletal muscle density; Skeletal muscle index.
© 2024 The Authors. Journal of Cachexia, Sarcopenia and Muscle published by Wiley Periodicals LLC.
Conflict of interest statement
The authors declare no potential conflicts of interest.
Figures




Similar articles
-
Associations of muscle and adipose tissue parameters with long-term outcomes in middle and low rectal cancer: a retrospective cohort study.Cancer Imaging. 2023 Jan 12;23(1):5. doi: 10.1186/s40644-022-00514-x. Cancer Imaging. 2023. PMID: 36635737 Free PMC article.
-
Preoperative myosteatosis and intermuscular adiposity as CT-Derived nutritional prognostic markers in colorectal cancer: A multicenter development-validation study.Clin Nutr. 2025 Aug 11;53:8-25. doi: 10.1016/j.clnu.2025.08.007. Online ahead of print. Clin Nutr. 2025. PMID: 40845425
-
Prognostic significance of the skeletal muscle index and systemic inflammatory index in patients with lymph node-positive breast cancer after radical mastectomy.BMC Cancer. 2022 Mar 3;22(1):234. doi: 10.1186/s12885-022-09312-x. BMC Cancer. 2022. PMID: 35241010 Free PMC article.
-
Visceral adiposity and inflammatory bowel disease.Int J Colorectal Dis. 2021 Nov;36(11):2305-2319. doi: 10.1007/s00384-021-03968-w. Epub 2021 Jun 9. Int J Colorectal Dis. 2021. PMID: 34104989 Review.
-
Muscle mass, assessed at diagnosis by L3-CT scan as a prognostic marker of clinical outcomes in patients with gastric cancer: A systematic review and meta-analysis.Clin Nutr. 2020 Jul;39(7):2045-2054. doi: 10.1016/j.clnu.2019.10.021. Epub 2019 Nov 1. Clin Nutr. 2020. PMID: 31718876
Cited by
-
Serum tumor marker and CT body composition scoring system predicts outcomes in colorectal cancer surgical patients.Eur Radiol. 2024 Dec;34(12):7596-7608. doi: 10.1007/s00330-024-10849-7. Epub 2024 Jun 24. Eur Radiol. 2024. PMID: 38913246 Free PMC article.
-
Body Composition and Progression of Biopsy-Proven Non-Alcoholic Fatty Liver Disease in Patients With Obesity.J Cachexia Sarcopenia Muscle. 2024 Dec;15(6):2608-2617. doi: 10.1002/jcsm.13605. Epub 2024 Oct 10. J Cachexia Sarcopenia Muscle. 2024. PMID: 39389917 Free PMC article.
-
Prognostic significance of preoperative CT-based sarcopenia in locally advanced rectal cancer: a multicenter retrospective study.BMC Cancer. 2025 Feb 14;25(1):261. doi: 10.1186/s12885-025-13664-5. BMC Cancer. 2025. PMID: 39953497 Free PMC article.
-
Targeting esophageal carcinoma: molecular mechanisms and clinical studies.MedComm (2020). 2024 Oct 15;5(11):e782. doi: 10.1002/mco2.782. eCollection 2024 Nov. MedComm (2020). 2024. PMID: 39415846 Free PMC article. Review.
-
Predicting 3-year all-cause mortality in rectal cancer patients based on body composition and machine learning.Front Nutr. 2025 Mar 3;12:1473952. doi: 10.3389/fnut.2025.1473952. eCollection 2025. Front Nutr. 2025. PMID: 40098743 Free PMC article.
References
-
- Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021;71:209–249. - PubMed
-
- Siegel RL, Miller KD, Goding Sauer A, Fedewa SA, Butterly LF, Anderson JC, et al. Colorectal cancer statistics, 2020. CA Cancer J Clin 2020;70:145–164. - PubMed
-
- Miller KD, Nogueira L, Devasia T, Mariotto AB, Yabroff KR, Jemal A, et al. Cancer treatment and survivorship statistics, 2022. CA Cancer J Clin 2022;72:409–436. - PubMed
-
- Araghi M, Soerjomataram I, Jenkins M, Brierley J, Morris E, Bray F, et al. Global trends in colorectal cancer mortality: projections to the year 2035. Int J Cancer 2019;144:2992–3000. - PubMed
-
- Perrin T, Lenfant M, Boisson C, Bert M, Rat P, Facy O. Effects of body composition profiles on oncological outcomes and postoperative intraabdominal infection following colorectal cancer surgery. Surg Obes Relat Dis 2021;17:575–584. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources